Skip to main content

28 September 2023

Last updated: Wednesday 27 September 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

JAK2 inhibitors: a breakthrough in oncology?

Thursday 23 September 2010

Interviewee/Contributor

Jürg Eckhardt

Organisation

Bellevue Asset Management

Organisations

Immunicum AB
AstraZeneca
Novartis
Lead Pharma BV
ERA Consulting (UK) Ltd
Immunocore Holdings Plc and Gadeta BV
AgomAb Therapeutics NV
MGB Biopharma Ltd
Fieldfisher LLP
RXi Pharmaceuticals Corp

Interviewees and Contributers

Peter Charlish
Lorna Ewart and Geraldine Hamilton
Renée Aguiar-Lucander
Richard Jones and Stephen Witte
Nicole Faust
Yasmin de Faria Krim
Mick Cooper
Cecil Nick
Andy Smith
Rob Meijer and Ilona Enninga

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Sanofi appoints new head of R&D

Sunday 17 September 2023

Rishi Shah to head chemistry at Ubiquigent

Sunday 17 September 2023

Christina Ackermann joins Verona Pharma

Sunday 17 September 2023

New CEO at Oxford Science Enterprises

Sunday 17 September 2023

Louis Kayitalire becomes CMO at Nanobiotix

Sunday 17 September 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form